Decheng Capital is a leading China venture capital firm that provides capital to early and growth stage life science companies. We are a team of investment professionals with complementary expertise, a long history of working together and a shared dedication to building highly successful companies that span the full spectrum of the life sciences industry. Our domain knowledge, access to innovative technologies and ability to bring proven Western products to China make us the preferred partner for entrepreneurs, domestic and multinational companies, government agencies and investors. Decheng Capital is poised to capitalize on a historic opportunity in China’s rapidly developing life sciences industry and to deliver superior returns for our investors.
June 6, 2013
Decheng Capital celebrates the final closing of USD Fund I
February 28, 2012
GeneWeave Biosciences Inks $12M
January 9, 2012
Decheng Capital to attend the JP Morgan Healthcare conference in San Francisco